---
title: Voiant vs Volumetryx
slug_a: voiantclinical
slug_b: volumetryx
site: cro
review_signal_gate: closed
canonical_path: /compare/voiantclinical/volumetryx
generated_by: BioBM Editorial AI
---

# Voiant vs Volumetryx

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Voiant (voiantclinical) is listed for cro. Voiant is the industry-leading imaging CRO for clinical trial imaging and endpoint adjudication, leveraging 30+ years of clinical expertise and AI-powered technology to deliver high-quality endpoint data across Phase I–IV global trials.

Services: 5. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Volumetryx (volumetryx) is listed for cro. Radiologist-founded oncology imaging CRO offering DICOM collect & hold, central reads by subspecialist radiologists, and AI-assisted volumetric analysis for Phase I/II trials. FDA 21 CFR Part 11, HIPAA, and GDPR compliant with 24–72 hour turnaround.

Services: 5. Modalities: 0. Indications: 1. Locations: 0. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.